Not Medicare Enrolled

Dr. Kathy Flanagan, M.D.

Forensic Psychiatry · Houston, TX
2211 NORFOLK ST, Houston, TX 77098
7135281570
Registered in NPPES since 2007
NPI: 1073662714 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Flanagan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Flanagan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Flanagan

Dr. Kathy Flanagan is a forensic psychiatry specialist in Houston, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Flanagan received a total of $476,757 from 32 pharmaceutical and/or device companies across 1013 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Flanagan is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $476,757 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$476,757
Total received (2018-2024)
Avg $68,108/year across 7 years
Top 8% in TX for forensic psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
1,013
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,710
2023
$586
2022
$9,920
2021
$115,303
2020
$63,515
2019
$155,513
2018
$126,211

Payments by company (2024)

Vanda Pharmaceuticals Inc.
$5,042
Inspire Medical Systems, Inc.
$277
ABBVIE INC.
$144
GENZYME CORPORATION
$131
Alexion Pharmaceuticals, Inc.
$116
Top 3 companies account for 95.7% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$279,482
AbbVie Inc.
$104,505
Allergan, Inc.
$73,889
ABBVIE INC.
$9,864
Vanda Pharmaceuticals Inc.
$5,042
Teva Pharmaceuticals USA, Inc.
$384
Shire North American Group Inc
$382
GlaxoSmithKline, LLC.
$345
Inspire Medical Systems, Inc.
$277
Janssen Pharmaceuticals, Inc
$238
SANOFI-AVENTIS U.S. LLC
$237
Sunovion Pharmaceuticals Inc.
$217
AstraZeneca Pharmaceuticals LP
$217
Alexion Pharmaceuticals, Inc.
$216
Novo Nordisk Inc
$192
GENZYME CORPORATION
$131
E.R. Squibb & Sons, L.L.C.
$125
FIDIA PHARMA USA INC.
$125
BioDelivery Sciences International, Inc.
$124
Abbott Laboratories
$122
Janssen Scientific Affairs, LLC
$121
Otsuka Pharmaceutical Development & Commercialization, Inc.
$100
BOSTON SCIENTIFIC CORPORATION
$100
ITI, Inc.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$64
ARBOR PHARMACEUTICALS, INC.
$56
Ironshore Pharmaceuticals Inc.
$27
Alkermes, Inc.
$25
Eisai Inc.
$25
Lundbeck LLC
$24
Avanir Pharmaceuticals, Inc.
$18
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 96.0% of all-time payments
Associated products mentioned in payments ›
AMPLATZER · ARISTADA · AUSTEDO · BELBUCA · BENLYSTA · CAPLYTA · Dayvigo · Evekeo · FANAPT · FARXIGA · HYMOVIS · INSPIRE · JORNAY PM · LATUDA · MYDAYIS · NUEDEXTA · Ozempic · PRALUENT · TRINTELLIX · Trintellix · ULTOMIRIS · VIIBRYD · VRAYLAR · VYVANSE · WATCHMAN · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a forensic psychiatry specialist in Houston?
Compare forensic psychiatrists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse forensic psychiatrists nearby

Geographic Context

Forensic psychiatrists in nearby ZIP areas
7
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
2.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Flanagan is a forensic psychiatry specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Flanagan receive payments from pharmaceutical companies?
Yes. Dr. Flanagan received a total of $476,757 from 32 companies across 1,013 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Flanagan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →